Somatostatin in the Treatment of Non-Variceal Upper Gastrointestinal Bleeding

Digestive Diseases

Volumn 16, Issue 4, 1998, Pages 214-224

  Jenkins, Spencer A ^a   Poulianos, George ^b   Coraggio, Francesco ^c   Rotondano, Gianluca ^c  

^a MORRISTON HOSPITAL   (United Kingdom)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Non variceal upper gastrointestinal bleeding; Octreotide; Peptic ulcers; Somatostatin; Vasoactive drugs

Indexed keywords

GASTROINTESTINAL AGENT; OCTREOTIDE; SOMATOSTATIN;

DIGESTIVE SYSTEM; DRUG EFFECT; GASTROINTESTINAL HEMORRHAGE; HUMAN; PEPTIC ULCER BLEEDING; REVIEW;

DIGESTIVE SYSTEM; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; OCTREOTIDE; PEPTIC ULCER HEMORRHAGE; SOMATOSTATIN;

EID: 0032113809     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016869     Document Type: Review

References (104)

1. Longstreth GF: Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: A population-based study. Am J Gastroenterol 1995;90:206-210.
2. Pundzius J: Clinical and endoscopic signs for the prediction of recurrent bleeding from gastroduodenal ulcers. Eur J Surg 1994;160:689-692.
3. Choudari CP, Rajgopal C, Elton RA, Palmer KR: Failures of endoscopic therapy for bleeding peptic ulcer: An analysis of risk factors. Am J Gastroenterol 1994;89:1968-1972.
4. Hsu P, Lin XZ, Chan SH, et al: Bleeding peptic ulcer-risk factors for rebleedmg and sequential changes in endoscopic findings. Gut 1994;35: 746-749.
5. Park KG, Steele RJ, Mollison J, Crofts TJ: Prediction of recurrent bleeding after endoscopic haemostasis in non-variceal upper gastrointestinal haemorrhage. Br J Surg 1994;81:1465-1468.
6. Jaramillo J, Galvez C, Carmona C, Montero JL, Mino G: Prediction of further haemorrhage in bleeding peptic ulcer. Am J Gastroenterol 1994;89:2135-2138.
7. Qvist P, Arnessen KE, Jacobson CD, Rosseland AR: Endoscopic treatment and restrictive surgical policy in the treatment of peptic ulcer bleeding. Five years' experience in a central hospital. Scand J Gastroenterol 1994;29:569-576.
8. Villanueva C, Balanzo J, Espinos JC, et al: Prediction of therapeutic failure in patients with bleeding peptic ulcers treated with endoscopic injection. Dig Dis Sci 1993;38:2062-2070.
9. Lin HJ, Perng CL, Lee PY, Lee CH, Lee SD: Clinical causes and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: A prospective study. Gut 1994; 35:1389-1393.
10. Heier SK, Gronowits SD, Willner IR, et al: The APACHE III prognostic system: Predicting adverse outcome after heater probe therapy. Gastroenterology 1995;108:A111.
11. Sambresqui A, Zylberman M, Foncuberta C, et al: Somatostatin for the treatment for upper gastrointestinal bleeding (UGIB) in patients undergoing autologous bone marrow transplantation (ABMT). Bone Marrow Transplant 1995;16:323-326.
12. Hall MN: An A to Z of British Medicines Research. London, Association of the British Pharmaceutical Industry, 1995, pp 20-21.
13. Morgan AG, Clamp SE: OMGE international gastrointestinal bleeding survey, 1978-1986. Scand J Gastroenterol Suppl 1988;44:51-58.
14. Rockall TA, Logan RFA, Devlin HB, Northfield TC: Incidence of and mortality from acute upper gastrointestinal haemorrhage in the UK. BMJ 1995;311:222-226.
15. Peterson WL, Barnett CC, Smith HJ, Allen MH, Corbett DB: Routine early endoscopy in upper gastrointestinal tract bleeding. A randomised controlled trial. N Engl J Med 1981; 304:925-929.
16. Rofe SM, Duggan JM, Smith ER, Thursby GJ: Conservative treatment of gastrointestinal haemorrhage. Gut 1985;26:481-484.
17. Madden MV, Griffith GH: Management of upper gastrointestinal bleeding in a district general hospital. J R Coll Phys Loud 1986;20:212-215.
18. Sacks HS, Chalmers TC, Blum AL, Berrier J, Pagano D: Endoscopic haemostasis: An effective therapy for bleeding ulcers. JAMA 1990;264:494-499.
19. Jones PF, Johnston SJ, McCewan AB, Kyle J, Needham CD: Further haemorrhage after admission to hospital for gastrointestinal haemorrhage. Br Med J 1973;iii:600-604.
20. Soll AH: Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice parameters. Committee of the American College of Gastroenterology. JAMA 1996;275:622-629.
21. Jensen DM: The Bleeding Ulcer: Stigmata, Needles, Probes and Antibiotics? ASGE Postgraduate Course. San Francisco, ASGE, 1996, pp 3-12.
22. Swain P: What should be done when initial endoscopic therapy for bleeding peptic ulcer fails? Endoscopy 1995;27:321-328.
23. Jensen DM, Cheng S, Kouacs TO, et al: A controlled study of ranitidine for the prevention of recurrent haemorrhage from duodenal ulcer. N Engl J Med 1994;300:382-386.
24. Van der Mierop F, Fleischer DE: Endoscopic hemostasis in nonvariceal bleeding: An overview. Endoscopy 1996;28:321-328.
25. Brullet E, Calvet X, Campo R, Rue M, Catot L, Donoso L: Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996;43:111-116.
26. Brullet E, Campo R, Calvet X: Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 1996;32:155-158.
27. Clason AE, MacLeod DAD, Elton RA: Clinical factors in the prediction of further haemorrhage or mortality in acute upper gastrointestinal bleeding. Br J Surg 1986;93:985-987.
28. Rockall TA, Logan RFA, Devlin HB, Northfield TC: Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38: 316-321.
29. Laine L: Medical progress: Bleeding peptic ulcer. N Engl J Med 1994;331:717-727.
30. Steffes CP, Sugawa C: Endoscopic management of nonvariceal gastrointestinal bleeding. World J Surg 1992;16:1025-1033.
31. Konturek SJ, Kwiechien H, Thulin L, Bielanski W, Oleksy T, Schally AV, Effect of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimuli in man. Scand J Gastroenterol 1985;20:31-38.
32. Creutzfeldt W, Arnold R: Somatostatin and the stomach: Exocrine and endocrine aspects. Metabolism 1978;27:1309-1315.
33. Mogard MH, Maxwell V, Kovacs T, et al: Somatostatin inhibits gastric acid secretion after gastric mucosal prostaglandin synthesis inhibition by indomethacin in man. Gut 1985; 26:1189-1191.
34. Sandvic A, Waldrum H: The effects of somatostatin on baseline and stimulated acid secretion and vascular histamine release from the totally isolated vascularly perfused rat stomach. Regul Pept 1988;20:233-239.
35. Gomez-Pan A, Reel J, Albinus M, Shaw B, Hall R: Direct inhibition of gastric acid and pepsin secretion by growth hormone in cats. Lancet 1974;i:888-890.
36. Hirschowitz BJPET: Somatostatin effects on gastric electrolytes and pepsin in dogs with various secretory stimuli. J Pharmacol Exp Ther 1987;243:501-506.
37. Li MKK, Sung JJY, Woo KS, et al: Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy. A randomised, double-blind crossover study. Dig Dis Sci 1996;41:2440-2446.
38. Panés J, Piqué JM, Bordas JM, et al: Effects of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994;20:336-341.
39. Krejs GJ: Physiological role of somatostatin in the digestive tract: Gastric acid secretion, intestinal absorption and motility. Scand J Gastroenterol 1986;2(suppl 119):47-53.
40. Arnold R, Lankisch PG: Somatostatin and the gastrointestinal tract. Clin Gastroenterol 1980; 9:733-753.
41. Peeters TL, Janssen J, Vantrappen C: Somatostatin and the intergastric migrating model complex in man. Regul Pept 1983;5:209-217.
42. Johansson C, Efendic S, Wisén O, Uvnäs-Wallensten K, Luft R: Effects of short-term somatostatin infusion on gastric and intestinal propulsion in humans. Scand J Gastroenterol 1978;13:481-482.
43. Johansson C, Wisén O, Efendic S, Uvnäs-Wallensten K: Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 1981;22:126-137
44. Johansson C, Ally A: Stimulation of gastric mucus output by somatostatin in man. Eur J Clin Invest 1982;12:37-39.
45. Green FW Jr, Kaplan MM, Curtis LE, Levine PH: Effect of acid and pepsin on blood coagula-tion and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.
46. Park J, Chiba T, Yamada T: Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin. J Biol Chem 1987,262: 14190-14196.
47. Reyl F, Silve C, Lewin MJM: Somatostatin receptors on isolated gastric cells, in Rosselin G, Fromagcot P, Bonfils S (eds): Hormone Receptors in Digestion and Nutrition. Amsterdam, Elsevier/North Holland, 1979, pp 391-400.
48. Giraud AS, Soll AH, Cuttitta F, Walsh JH: Bombesin stimulation of gastrin release from canine gastrin cells in primary culture. Am J Physiol 1987;252:G413-G420.
49. Etherington DJ, Tayler WH: Nomenclature of pepsins. Nature 1967;216:279-280.
50. Taylor WH: Pepsin in patients with peptic ulcer disease. Nature 1976;277:760-767.
51. Walker V, Taylor WH: Pepsin I secretion in chronic peptic ulceration. Gut 1980;21:776-781.
52. Pearson JP, Ward R, Allen A, Roberts NB, Taylor WH: Mucus degradation by pepsin I: Implications in peptic ulceration. Gut 1986;27: 243-248.
53. Beistad A, Holm HA, Kittang E: Experience with antipeptic agents. Scand J Gastroenterol 1979;14(suppl 55):121-123.
54. Becker R, Scholtholt J, Speth O, Scholkens B: Regional blood flow and haemodynamics in anaesthetised dogs during somatostatin-secretin infusion (abstract). Arch Pharmacol 1981; 316(suppl):R46.
55. McCormick PA, Jenkins SA, McIntyre N, Burroughs AK: Why portal hypertensive varices bleed and bleed: A hypothesis. Gut 1995;36: 100-102.
56. Gabryelewicz A, Prokopowicz J, Hnidec O, Wolosowicz N: The effect of chronic administration of somatostatin on the hemostatic system in the dog. Przegl Lek 1981;38:719-721.
57. Szabo S, Usadel KH: Cytoprotection-organo-protection by somatostatin: Gastric and hepat-ic lesions. Expenentia 1982;38:254-256.
58. Usadel KH, Kessler H, Rohr G, Kusterer K, Palitzsch KD, Schwedes U: Cytoprotective properties of somatostatins. Klin Wochenschr 1986;64(suppl 7):59-63.
59. Greco AV, Bianco A, Altomonte L, D'Acquarica L, Ghirlanda G: Effect of somatostatin on lower csophageal sphincter (les) pressure and serum gastrin in normal and achalasic subjects. Horm Metab Res 1982;14:26-28.
60. Caldwell MTP, Marks P, Byrne PJ, Walsh TN, Hennessy TPJ: Hypotension induced by haemorrhage impairs lower oesophageal sphincter function.Br J Surg 1994;81:1517-1519.
61. Straathoff JW, Tieleman S, Lamers CBHW, Masclee AAM: Somatostatin prevents meal induced alterations in lower esophageal sphincter function. Gut 1996;39(suppl 3):1039.
62. Whitehouse I, Beglinger C, Fried M, Gyr K: The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 on pentagastrin-stimulated gastric acid secretion: A comparative study in man. Hepatogastroenterologica 1984;31:227-229.
63. Whitehouse I, Beglinger C, Ruettimann C, Gyr K: Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue. Gut 1986;27: 141-146.
64. Olson JA, Loud FB, Christianssen J: Inhibition of meal stimulated gastric acid secretion by the octapeptide somatostatin analogue SMS 201-995. Gut 1987;28:464-467.
65. Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I: Effect of the somatostatin analogue Sandostatin (SMS 201-995) on gastrointestinal pancreatic and biliary function and hormone release in normal man. Digestion 1987;36:108-124.
66. Konturek SJ, Cieszkowski JB, Konturek J, Bielanski W, Schally AV: Effects of cyclic hexapeptide analogue of somatostatin on pancreatic secretion in dogs. Proc Soc Exp Biol Med 1985; 178:68-72.
67. Williams ST, Weltering EA, O'Dorisio TM, Fletcher WS: Effect of octreotide acetate on pancreatic exocrine function. Am J Surg 1989; 157:459-462.
68. Kohler E, Beglinger C, Dettwiler S, Whitehouse I, Gyr K: Effect of a new somatostatin analogue on pancreatic function in healthy volunteers. Pancreas 1986;1:154-159.
69. Baxter JN, Jekins SA, Ellenbogen S, Roberts N: The effects of a somatostatin analogue SMS 201-995 on pancreatic secretion in the pig and man. Surg Res Commun 1988;4:215-228.
70. 99mTc-tin colloid and mouth to caecum transit time in man. Digestion 1987:36:101-107.
71. Dueno MI, Bai JC, Santangelo WC, Krejs GJ: Effect of somatostatin analogue on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci 1987;32:1092-1096.
72. Moller N, Petrany C, Cassidy D, Sheldon WL, Johnston DG, Laker MF: Effects of the somatostatin analog SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrate in normal man. Clin Sci 1988;75:345-350.
73. Richards WO, Geer R, O'Dorisio TM, et al: Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J Surg Res 1990;49:483-487.
74. Londong W, Angerer M, Kutz K, Landgraf R, Londong V: Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration. Gastroenterology 1989;96:713-722.
75. Hollenberg MD: Control of receptor function by homologous and heterologous ligands; in Poste C, Crooke ST (eds): Mechanisms of Receptor Regulation. New York, Plenum Press, 1985, pp 295-322.
76. Somerville KW, Davies JG, Hawkey CJ, Henry DA, Hine KR, Langman MJS: Somatostatin in treatment of haematemesis and melaena. Lancet 1985;i:130-132.
77. Wagner PK, Rothmund M, Grönniger J: Sekretin versus Somatostatin bei akuter Blutung aus gastroduodenalen Ulcera und Erosionen, eine randomisierte Studie. Klin Wochenschr 1983; 61:285-289.
78. Galmiche JP, Cassigneul J, Faivre J, et al: Somatostatin in peptic ulcer bleeding: Results of a double-blind controlled trial. Int J Clin Pharmacol Res 1983;3:379-387.
79. Basso N, Bagarani M, Bracci F, et al: Ranitidine and somatostatin. Their effects on bleeding from the upper gastrointestinal tract. Arch Surg 1986;121:833-835.
80. Saperas E, Piqué JM, Pérez-Ayuso R, et al. Somatostatin compared with cimetidine in the treatment of bleeding peptic ulcer without visible vessel. Aliment Pharmacol Ther 1988;2: 153-159.
81. Kayasseh L, Keller U, Gyr K, Stalder GA: Somatostatin and cimetidine in peptic-ulcer haemorrhage. Lancet 1980;i: 844-846.
82. Coraggio F, Scarpato P, Spina M, Lombardi S: Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. Br Med J 1984;289:224.
83. Magnusson I, Ihre T, Johansson C, Seligson U, Törngren S, Uvnäs-Moberg K: Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut 1985;26:221-226.
84. Antonioli A, Gandolfo M, Rigo GP, et al: Somatostatin and cimetidine in the control of acute upper gastrointestinal bleeding. A controlled multicenter study. Hepatogastroenterology 1986:33:71-74.
85. Torres AJ, Landa I, Hernández F, et al: Somatostatin in the treatment of severe upper gastrointestinal bleeding: A multicentre controlled trial. Br J Surg 1986:73:786-789.
86. Lambropoulos LG, Greca A, Bakaris T, Flevaris CP: Somatostatin effectiveness in serious upper gastrointestinal hemorrhage (abstract). Gut 1996;39(suppl 3):204.
87. Bosch J, D'Amico G, Luca A, Garica-Pagan JC, Feu F, Escorsell A: Drug therapy for variceal hemorrhage; in Bosch J, Groszmann RJ (eds): Portal Hypertension. Pathophysiology and Treatment. Cambridge, Blackwell, 1994, pp 108-123.
88. Jenkins SA: Emerging Differences in the Therapeutic Efficacy of Somatostatin and Octreotide in Gastroenterology and Surgery. Hong Kong, MediMedia Asia, 1996, pp 1-160.
89. D'Amico G, Pagliaro L, Bosch J: The treatment of hypertension: A meta-analytic review. Hepatology 1995;22:332-354.
90. Coraggio F, Catalano A, Masetto O, Moles DA, Rotondano G: The octreotide in the conservative treatment of upper digestive haemorrhages due to peptic lesions (abstract 6). Hepatogastroenterology 1990;37(suppl II):37.
91. Coraggio F, Bertini G, Catalano A, Scarpato P, Gualdieri L: Clinical, controlled trial of somatostatin with ranitidine and placebo in the control of peptic haemorrhage of the upper gastrointestinal tract. Digestion 1989;43:190-195.
92. Coraggio F, Rotondano G: Somatostatin in acute upper gastrointestinal bleeding due to peptic lesions. Retrospective review 1988-1993 (honorary lecture). Proc 2nd Natl Congr Emergency Medicine, Naples, Casa Editrice L'Antologia, 1995.
93. Tulassay Z, Gupta R, Papp J, Bodnár A: Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: A prospective, randomised, controlled trial. Am J Gastroenterol 1989;84:6-9.
94. Coraggio F, Rotondano G, Balzanelli MG, Catalano A, Clemente F, Moccia F: Somatostatin prevents recurrent bleeding after endoscopic hemostasis of peptic ulcer haemorrhage: A preliminary report. Eur J Gastroenterol Hepatol 1998, in press.
95. Christiansen J, Ottenjann R, Von Arx F: Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding. Gastroenterology 1989;97:468-574.
96. Lin HJ, Perng CL, Wang K, Lee CH, Lee SD: Octreotide for arrest of peptic ulcer haemorrhage: A prospective, randomized controlled trial. Hepatogastroenterology 1995;42:856-860.
97. Lin HJ, Wang K, Perng CL, Chua RT, Lee CH, Lee SD: Octreotide and heater probe thermocoagulation for arrest of peptic ulcer hemor-rhage. A prospective, randomised, controlled trial. J Clin Gastroenterol 1995;21:95-98.
98. Burroughs AK, Jenkins SA: Management strategies in bleeding oesophageal varices. Drugs 1992;44:(suppl 2): 1-72.
99. Graham DY, Smith JL: The course of patients after variceal haemorrhage. Gastroenterology 1981;80:800-809.
100. Pagliaro L, Burroughs AK, Sorenson TA, et al: Therapeutic controversies and randomised controlled trials: Prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Int 1989;2:71-84.
101. Lin HJ, Wang K, Perng CL, Lee FY, Lee CH, Lee SD: Natural history of bleeding peptic ulcers with a tightly adherent blood clot: A prospective observation. Gastrointest Endosc 1996;43:470-473.
102. McLeod IA, Mills PR: Factors identifying the probability of further haemorrhage after acute upper gastrointestinal haemorrhage. Br J Surg 1982;69:256-258.
103. Perng CL, Lin HJ, Chen CJ, Lee FY, Lee SD, Lee CH: Characteristics of patients with bleeding peptic ulcer requiring emergency endoscopy and aggressive treatment. Am J Gastroemerol 1994;89:1811-1814.
104. 2-antagonists and placebo in the management of acute non-variceal upper gastrointestinal haemorrhage: A meta-analysis. Ann Intern Med 1997; 127: 1062-1071.